Basic and applied myology | |
Chemotherapy-induced muscle wasting: association with NF-κB and cancer cachexia | |
Michael E. Stadler1  Denis C. Guttridge1  Albert S. Baldwin2  Swarnali Acharyya3  Jeffrey S. Damrauer4  Marion E. Couch4  | |
[1] Medical Genetics, The Ohio State University, Biomedical Research Tower, Arthur G. James Comprehensive Cancer Center, Columbus, Ohio;Neck Surgery, University of North Carolina School of Medicine, Neurosciences Hospital, North Carolina;Department of Otolaryngology-Head &Human Cancer Genetics, Department of Molecular Virology, Immunology &Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina | |
关键词: Cancer; cachexia; NF-κB; chemotherapy; skeletal muscle; wasting.; | |
DOI : 10.4081/ejtm.2018.7590 | |
学科分类:农业科学(综合) | |
来源: Pagepress | |
【 摘 要 】
A compounding feature of greater than 50% of all cancers is the high incidence of the cachexia syndrome, a complex metabolic disorder characterized by extreme weight loss due mainly to the gross depletion of skeletal muscle tissue. Although studies into the cause of cancer cachexia has spanned over multiple decades, little is known about the effects of various cancer treatments themselves on cachexia. For example, chemotherapy agents induce side effects such as nausea and anorexia, but these symptoms do not fully account for the changes seen with cancer cachexia. In this study we examine the effects of chemotherapeutic compounds, specifically, cisplatin in the colon-26 adenocarcinoma model of cancer cachexia. We find that although cisplatin is able to reduce tumor burden as expected, muscle wasting in mice nevertheless persists. Strikingly, cisplatin alone was seen to regulate muscle atrophy, which was independent of the commonly implicated ubiquitin proteasome system. Finally, we show that cisplatin is able to induce NF-κB activity in both mouse muscles and myotube cultures, suggesting that an additional side effect of cancer treatment is the regulation of muscle wasting that may be mediated through activation of the NF-κB signaling pathway.
【 授权许可】
CC BY
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO201910256721132ZK.pdf | 875KB | download |